what type of drug is nembutal Secrets
what type of drug is nembutal Secrets
Blog Article
pentobarbital decreases levels of ponatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Steer clear of unless the coadministration outweighs the attainable chance of ponatinib underexposure; observe for signs of decreased efficacy.
fentanyl transmucosal and pentobarbital both boost sedation. Stay away from or Use Alternate Drug. Limit use to clients for whom different remedy possibilities are inadequate
pentobarbital will reduce the level or effect of irinotecan liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
fentanyl intranasal and pentobarbital both increase sedation. Stay clear of or Use Alternate Drug. Restrict use to sufferers for whom alternative treatment method options are insufficient
pentobarbital will reduce the level or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
pentobarbital will lower the level or effect of indinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Contraindicated (1)pentobarbital will reduce the level or effect of fostemsavir by influencing hepatic/intestinal enzyme read more CYP3A4 metabolism.
pentobarbital will decrease the level or impact of buspirone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital decreases amounts of vandetanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration with strong CYP3A4 inducers; these drugs reduce exposure to vandetanib by as much as 40%.
Contraindicated (one)pentobarbital will decrease the level or outcome of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will enhance the stage or impact of ivosidenib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration of ivosidenib with robust CYP3A4 inducers decreased ivosidenib plasma concentrations.
pentobarbital will increase toxicity of buprenorphine, extensive-performing injection by pharmacodynamic synergism. Modify Therapy/Keep an eye on Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants increases chance of adverse reactions which includes overdose, respiratory depression, and Dying. Cessation of benzodiazepines or other CNS depressants is chosen generally.
pentobarbital will lower the level or result of amlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will decrease the level or effect of ziprasidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.